Identification of Low Molecular Weight Pyroglutamate A Oligomers in Alzheimer Disease
نویسندگان
چکیده
Oliver Wirths, Christian Erck, Henrik Martens, Anja Harmeier, Constanze Geumann, Sadim Jawhar, Sathish Kumar , Gerd Multhaup, Jochen Walter , Martin Ingelsson**, Malin Degerman-Gunnarsson**, Hannu Kalimo, Inge Huitinga, Lars Lannfelt**, and Thomas A. Bayer From the Department of Molecular Psychiatry and Alzheimer, Graduate School, University Medicine Goettingen, 37075 Goettingen, Germany, Synaptic Systems, 37079 Göttingen, Germany, the Institute of Chemistry and Biochemistry, Free University of Berlin, 14195 Berlin, Germany, the Department of Neurology, Molecular Cell Biology, University of Bonn, 53127 Bonn, Germany, the **Department of Public Health and Caring Sciences Rudbeck Laboratory, Uppsala University, SE 75185 Uppsala, Sweden, the Department of Pathology, University of Helsinki, FI-00014 Helsingin yliopisto, Finland, and the Netherlands Brain Bank, Netherlands Institute for Neuroscience, 1105 BA Amsterdam, Netherlands
منابع مشابه
A novel inhibitor of amyloid β (Aβ) peptide aggregation: from high throughput screening to efficacy in an animal model of Alzheimer disease.
Compelling evidence indicates that aggregation of the amyloid β (Aβ) peptide is a major underlying molecular culprit in Alzheimer disease. Specifically, soluble oligomers of the 42-residue peptide (Aβ42) lead to a series of events that cause cellular dysfunction and neuronal death. Therefore, inhibiting Aβ42 aggregation may be an effective strategy for the prevention and/or treatment of disease...
متن کاملStrain-specific Fibril Propagation by an Aβ Dodecamer
Low molecular weight oligomers of amyloid-β (Aβ) have emerged as the primary toxic agents in the etiology of Alzheimer disease (AD). Polymorphism observed within the aggregation end products of fibrils are known to arise due to microstructural differences among the oligomers. Diversity in aggregate morphology correlates with the differences in AD, cementing the idea that conformational strains ...
متن کاملAlzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X
Full-length Aβ1-42 and Aβ1-40, N-truncated pyroglutamate Aβ3-42 and Aβ4-42 are major variants in the Alzheimer brain. Aβ4-42 has not been considered as a therapeutic target yet. We demonstrate that the antibody NT4X and its Fab fragment reacting with both the free N-terminus of Aβ4-x and pyroglutamate Aβ3-X mitigated neuron loss in Tg4-42 mice expressing Aβ4-42 and completely rescued spatial re...
متن کاملFamilial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques.
Familial Danish dementia is an early onset autosomal dominant neurodegenerative disorder linked to a genetic defect in the BRI2 gene and clinically characterized by dementia and ataxia. Cerebral amyloid and preamyloid deposits of two unrelated molecules (Danish amyloid (ADan) and beta-amyloid (Abeta)), the absence of compact plaques, and neurofibrillary degeneration indistinguishable from that ...
متن کاملIn Vitro and In Vivo Neurotoxicity of Prion Protein Oligomers
The mechanisms underlying prion-linked neurodegeneration remain to be elucidated, despite several recent advances in this field. Herein, we show that soluble, low molecular weight oligomers of the full-length prion protein (PrP), which possess characteristics of PrP to PrPsc conversion intermediates such as partial protease resistance, are neurotoxic in vitro on primary cultures of neurons and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010